AG000F85

114798-26-4 | 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol

AG000F85

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	114798-26-4
Catalog Number	AG000F85(AGN-PC-04RQSQ)
Chemical Name	2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol
EC Number	601-329-8
IUPAC Name	[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
InChI	InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)
InChI Key	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
MDL Number	MFCD00865831
Molecular Formula	C22H23ClN6O
Molecular Weight	422.9106
NSC Number	758699
SMILES	C(n1c(CCCC)nc(c1CO)Cl)c1ccc(cc1)c1c(cccc1)c1[nH]nnn1
UNII	JMS50MPO89
Synonyms	2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, Cozaar, DuP 753, DuP-753, DuP753, Losartan, Losartan Monopotassium Salt, Losartan Potassium, MK 954, MK-954, MK954, Monopotassium Salt, Losartan, Potassium, Losartan, Salt, Losartan Monopotassium, losartan, 114798-26-4, DUP 89, Lortaan, LOSARTAN POTASSIUM, Cozaar, Hyzaar, Losartan [INN:BAN], Losartan monopotassium salt, UNII-JMS50MPO89, C22H23ClN6O, DuP-753, CHEBI:6541, MK-954, JMS50MPO89, 2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, DuP 753, MFCD00865831, (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol, [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol, 2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole, NCGC00095125-01, DSSTox_CID_3227, DSSTox_RID_76933, DSSTox_GSID_23227, (1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol, 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'- biphenyl)-4-yl)methyl)-, Q-201321, [3H]losartan, HSDB 7043, Losartan (INN), Losartic (TN), 1H-imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 2-BUTYL-4-CHLORO-1-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-METHANOL, [3H]-losartan, CAS-114798-26-4, MK954, SR-01000763170, [2-butyl-5-chloro-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol, PubChem9176, Dup89, Spectrum_001713, SCHEMBL60, Spectrum2_001677, Spectrum3_000998, Spectrum4_001126, Spectrum5_001466, Epitope ID:140137, EC 601-329-8, AC1L1H3Q, Oprea1_644635, US9624243, Losartin, BSPBio_002695, GTPL590, KBioGR_001611, KBioSS_002193, BIDD:GT0286, SPECTRUM1504268, SPBio_001893, DUP-89, GTPL3941, Jsp001094, DTXSID7023227, BDBM82258, CTK8E7663, KBio2_002193, KBio2_004761, KBio2_007329, KBio3_001915, PSIFNNKUMBGKDQ-UHFFFAOYSA-N, BCPP000183, BDBM318822, HMS1922J13, HMS2093E22, HMS3715L11, Pharmakon1600-01504268, BCP27731, KS-00000GI2, NSC_3961, ZINC3873160, Tox21_111435, BG0556, CCG-39095, GP6564, NSC758699, STL419984, 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol, AKOS015917390, AKOS015994740, Tox21_111435_1, AB07507, API0007066, BCP9000861, CS-2116, DB00678, KS-5004, MCULE-5204931675, NSC-758699, 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole, NCGC00095125-02, NCGC00095125-03, NCGC00095125-05, (2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol, 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol, AK326126, AN-15301, HY-17512, I497, LS-78746, SC-47229, SBI-0206766.P001, AB0013723, RT-013597, CAS_114798-26-4, FT-0631074, C07072, D08146, 54244-EP2269989A1, 54244-EP2270011A1, 54244-EP2272841A1, 54244-EP2277879A1, 54244-EP2287165A2, 54244-EP2287166A2, 54244-EP2292620A2, 54244-EP2295053A1, 54244-EP2295406A1, 54244-EP2298772A1, 54244-EP2298776A1, 54244-EP2298779A1, 54244-EP2301923A1, 54244-EP2301931A1, 54244-EP2301936A1, 54244-EP2305219A1, 54244-EP2308562A2, 54244-EP2308839A1, AB01563296_01, 798L264, A803239, L000351, I14-9710, SR-01000763170-3, SR-01000763170-4, BRD-K76205745-001-02-5, BRD-K76205745-001-04-1, F2173-0506, [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-imidazolyl]methanol, 2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl)methyl]imidazole, 2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole, (1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, (1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, (1-((2'-(2h-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1h-imidazol-5-yl)methanol, (2-butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol, [2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol, {2-Butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazol-4-yl}-methanol, 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI), 2-butyl-4-chloro-1-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol, 2-butyl-4-chloro-5-(hydroxymethyl)-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole, allisartan, Lacidipine, Angizaar, Losartic, Mixture Name, Potassium, Losartan, Cozaar (TN), losartan monopotassium, CHEMBL191, D03AQG, D0DD0K, DuP753, Monopotassium Salt, Losartan, Salt, Losartan Monopotassium, C22-H23-Cl-N6-O, CID3961, MK 954, CL23623, CS-O-10833, 1645A, B1072, D019808, (2-Butyl-4-chloro-1-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)-1H-imidazol-5-yl)methanol, 1-[1-[[2'-(2H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-butyl-4-chloro-1H-imidazol-5-yl]methanol, 1h-imidazol-5-metanol, 2-butil-4-cloro-1-[[2'-(2h-tetrazol-5-il)[1,1'-bifenil]-4-il]metil]-, 1H-Imidazole-5-methanol 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1 1'-biphenyl]-4-yl]methyl]-(9CI), 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI), 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1 1'-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol, 90776-59-3, LSN,

Complexity	520
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	422.162g/mol
Formal Charge	0
Heavy Atom Count	30
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	422.917g/mol
Monoisotopic Mass	422.162g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	92.5A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number